A supplemental report is being submitted for additional information.Newly received information indicated that the date of event was (b)(6) 2020.B3 date of event updated from (b)(6) 2020.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
A supplemental report is being submitted for additional information and device evaluation.D4 model # updated from unk to 1430us, catalog # updated from unk to 1430us, expiration date updated from 31-dec-2021 to 20-nov-2021 and unique identifier (udi) updated from asku to (b)(4).H4 device manufacture date updated from 31-jan-2020 to 20-dec-2019.Product event summary: the controller ac adapter was returned for evaluation.Various analyses were conducted and reviewed in order to evaluate the performance of the device in relation to the reported event.A review of the manufacturing documentation confirmed that the associated device met all requirements for release.Failure analysis of the returned controller ac adapter revealed that the unit passed functional testing.The adapter was able to connect securely to a test controller and provide power.As received, all of the clamp assembly screws were present.As a result, the reported missing screw event could not be confirmed.However, external visual inspection revealed that the clamp assembly was unmounted from the housing and was missing a clamp nut on the power cord receptacle.During internal visual inspection, the clamp nut was found within the adapter's enclosure, detached from the receptacle.The detached clamp nut prevented the clamp assembly from properly mounting to the power receptacle, thus confirming the reported poor mechanical connection event.During internal visual inspection, it was noted that the adhesive around the clamp nut was present and had solidified properly.Based on the available information, a possible root cause of the damaged clamp assembly event can be attributed to the handling of the device.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|